Soricimed to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference
Back to Newsroom
Mentioned in this Article

Soricimed to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

Tuesday, December 3, 2019 8:00 AM
Share this article now
Topic:
Company Update

TORONTO, ON / ACCESSWIRE / December 3, 2019 / Soricimed, a privately-held, science-based company focused on the development and commercialization of drug candidates for the treatment of solid-tumor cancers, environmentally responsible pesticides and novel active skin-care products, announced today that management will present an update on the Company's business at the first annual BioTuesdays Pre-JPM Virtual Conference on Tuesday, December 10, 2019 at 1:30 p.m. Eastern Time.

The live and archived presentation webcast can be accessed here.

About Soricimed Biopharma Inc.: Soricimed is a privately-held, science-based company focused on the development and commercialization of applications originally derived from its unique and proprietary family of peptides found in the paralytic venom of the northern short-tailed shrew. Product development is ongoing for three distinct verticals: as targeted drug candidates for the treatment of solid-tumor cancers; as an environmentally responsible pesticide for the agriculture and aquaculture sectors; and as novel active ingredients in skin-care products for the cosmetic industry. For more information visit www.soricimed.com.

Media Relations:

Julie A. Fotheringham
Partner, HAGEMAN Communications
[email protected]
416.951.7988

Investor Relations:

Stephen Kilmer
President, Kilmer Lucas Inc.
[email protected]
646.274.3580

SOURCE: Soricimed Biopharma

Soricimed Biopharma
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: